IRIS
ORSO, Francesca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 481
NA - Nord America 176
AS - Asia 123
SA - Sud America 1
Totale 781
Salva come PNG Salva come JPEG
Nazione #
IE - Irlanda 279
US - Stati Uniti d'America 175
DE - Germania 81
HK - Hong Kong 64
IT - Italia 59
SG - Singapore 34
SE - Svezia 31
VN - Vietnam 18
FI - Finlandia 12
UA - Ucraina 9
CN - Cina 6
NL - Olanda 6
CZ - Repubblica Ceca 2
BE - Belgio 1
CA - Canada 1
CL - Cile 1
GB - Regno Unito 1
IN - India 1
Totale 781
Salva come PNG Salva come JPEG
Città #
Dublin 279
Hong Kong 64
Mülheim 49
Singapore 21
Jacksonville 17
Dong Ket 16
Turin 12
Bremen 11
Dearborn 10
Milan 9
Helsinki 8
Piemonte 8
Boardman 7
Amsterdam 6
New York 5
Lawrence 4
Munich 4
Novara 4
Princeton 4
Ashburn 3
Beijing 3
Wilmington 3
Andover 2
Berlin 2
Brno 2
Francavilla al Mare 2
Hanoi 2
Naples 2
Rapallo 2
San Giorgio di Nogaro 2
San Mateo 2
San Mauro Torinese 2
Trecate 2
Ann Arbor 1
Bangalore 1
Chengdu 1
Dreieich 1
Hefei 1
Jena 1
Lappeenranta 1
Louvain 1
Monmouth Junction 1
Nanchang 1
Noicattaro 1
Norwalk 1
Rome 1
Termini Imerese 1
Toronto 1
Totale 584
Salva come PNG Salva come JPEG
Nome #
VEGF blockade enhances the antitumor effect of BRAFV600E inhibition 73
Identification of functional TFAP2A and SP1 binding sites in new TFAP2A-modulated genes 55
TCR gene transfer with lentiviral vectors allows efficient redirection of tumor specificity in naïve and memory T-cells without prior stimulation of endogenous TCR 44
microRNA-222 controls neovascularization by regulating signal transducer and activator of transcription 5A expression 26
Stroma-derived miR-214 coordinates tumor dissemination 23
Antitumoral effects of attenuated Listeria monocytogenes in a genetically engineered mouse model of melanoma 22
MicroRNA-Mediated Metabolic Shaping of the Tumor Microenvironment 20
Dysregulation of Blimp1 transcriptional repressor unleashes p130Cas/ErbB2 breast cancer invasion 20
Axl-148b chimeric aptamers inhibit breast cancer and melanoma progression 19
mTORC1/autophagy-regulated MerTK in mutant BRAFV600 melanoma with acquired resistance to BRAF inhibition 19
ESDN inhibits melanoma progression by blocking E-selectin expression in endothelial cells via STAT3 18
Mir-214 and mir-148b targeting inhibits dissemination of melanoma and breast cancer 17
Role of coactivators and corepressors in steroid and nuclear receptor signaling: potential markers of tumor growth and drug sensitivity 16
AP-2{alpha} and AP-2{gamma} regulate tumor progression via specific genetic programs 15
Formation of STAT5/PPAR{gamma} Transcriptional Complex Modulates Angiogenic Cell Bioavailability in Diabetes 15
Identification of p130Cas/ErbB2-dependent invasive signatures in transformed mammary epithelial cells 15
Activator protein-2gamma (AP-2gamma) expression is specifically induced by oestrogens through binding of the oestrogen receptor to a canonical element within the 5'-untranslated region 15
AP-2alpha regulates migration of GN-11 neurons via a specific genetic programme involving the Axl receptor tyrosine kinase 15
miR-21 coordinates tumor growth and modulates KRIT1 levels 15
Macrophage miR-210 induction and metabolic reprogramming in response to pathogen interaction boost life-threatening inflammation 15
Therapeutic Silencing of miR-214 Inhibits Tumor Progression in Multiple Mouse Models 15
AGO2 promotes telomerase activity and interaction between the telomerase components TERT and TERC 14
Role of miRNAs in tumor and endothelial cell interactions during tumor progression 14
miR-214 coordinates melanoma progression by upregulating ALCAM through TFAP2 and miR-148b downmodulation 13
3-phosphoinositide-dependent kinase 1 controls breast tumor growth in a kinase-dependent but Akt-independent manner 13
The RNA-binding protein ESRP1 promotes human colorectal cancer progression 13
RICTOR/mTORC2 downregulation in BRAFV600E melanoma cells promotes resistance to BRAF/MEK inhibition 12
miR-135b coordinates progression of ErbB2-driven mammary carcinomas through suppression of MID1 and MTCH2 12
MiR-146a exerts differential effects on melanoma growth and metastatization 12
microRNAs converge on the transcription factor FOXP2 and promote breast cancer metastasis 11
Interference with Activator Protein-2 transcription factors leads to induction of apoptosis and an increase in chemo- and radiation- sensitivity in breast cancer cells 11
microRNA-214 contributes to melanoma tumor progression through suppression of TFAP2C 11
miR-214 as a Key Hub that Controls Cancer Networks: Small Player, Multiple Functions 11
miR-223 is a coordinator of breast cancer progression as revealed by bioinformatics predictions 10
Do predicted microRNAs control gene networks involved in breast cancer progression? 10
Analysis of the regulatory regions of AP-2alpha-modulated genes selected for oral presentation and winner of the "Premio Chiara D'Onofrio Giovani Riercatori 2009" 10
Do predicted microRNAs control gene networks involved in breast cancer progression? 10
A computational pipeline to identify new potential regulatory motifs in melanoma progression. 9
The power of microRNAs as diagnostic and prognostic biomarkers in liquid biopsies 9
p130Cas/Cyclooxygenase-2 axis in the control of mesenchymal plasticity of breast cancer cells 9
microRNA-214 contributes to melanoma tumor progression through suppression of TFAP2C 8
ACTIVATOR PROTEIN-2 ALPHA TRANSCRIPTION FACTOR ROLES IN NEURONS 8
miR-148b is a major coordinator in a Relapse-associated miR signature in Breast Tumors 8
Expression of AP-2a, AP-2g and ESDN in primary melanomas: Correlation with histopathological features and potential prognostic value 7
The AP-2alpha and AP-2gamma transcription factors regulate tumor formation 7
POSSIBLE OESTROGENIC EFFECTS ON AP-2 ALPHA EXPRESSION AND AP-2 ALPHA POTENTIAL ROLE IN nNOS REGULATION IN MOUSE HYPOTHALAMUS 7
miR148b is a major coordinator of breast cancer progression in a relapse-associated microRNA signature by targeting ITGA5, ROCK1, PIK3CA, NRAS and CSF1 7
microRNA and cancer progression in Breast Tumours 7
The role of melatonin on miRNAs modulation in triple-negative breast cancer cells 6
Dihydroorotate dehydrogenase inhibition reveals metabolic vulnerability in chronic myeloid leukemia 6
Identification and characterization of microRNAs involved in tumor progression and metastasis 6
Emerging roles of 3D-culture systems in tackling tumor drug resistance 5
CyTRANSFINDER: A Cytoscape 3.3 plugin for three-component (TF, gene, miRNA) signal transduction pathway construction 5
DIFFERENTIAL REGULATION OF AP-2 GENES BY ESTROGEN IN HUMAN BREAST CANCER CELLS 5
The AP-2alpha and AP-2gamma transcription factors regulate tumor progression and cell movement via specific genetic programs 5
DIFFERENTIAL REGULATION OF AP-2 TRANSCRIPTION FACTOR GENE EXPRESSION BY ESTROGEN IN HUMAN BREAST CANCER CELLS 5
Co-localization of AP2alpha transcription factor and TH-immunoreactive neurons in mouse locus coeruleus 5
miRNA-guided reprogramming of glucose and glutamine metabolism and its impact on cell adhesion/migration during solid tumor progression 4
The Ap-Alpha transcription factor regulates tumor cell migration 4
High IGFBP2 expression correlates with tumor severity in pediatric rhabdomyosarcoma 4
Investigating the epi-miRNome: Identification of epi-miRNAs using transfection experiments 4
PD-L1 up-regulation in melanoma increases disease aggressiveness and is mediated through miR-17-5p 4
miR-15a targets the HSP90 co-chaperone Morgana in chronic myeloid leukemia 3
Identification of new AP-2alpha regulated genes: a biological and bioinformatic approach 3
Totale 839
Salva come PNG Salva come JPEG
Categoria #
all - tutte 8.122
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.122
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202034 0 0 3 1 6 6 7 2 4 1 3 1
2020/202138 3 0 3 4 3 0 3 0 3 0 3 16
2021/202220 0 2 0 4 1 0 2 0 3 1 1 6
2022/2023426 6 2 2 1 11 24 3 31 249 36 58 3
2023/2024284 17 18 40 17 61 3 42 7 3 2 25 49
2024/202511 11 0 0 0 0 0 0 0 0 0 0 0
Totale 839